ScholarIQanswers from OpenAlex & ORCID
Stephen J. O’Keefe
ResearcherPublications, citations & collaboration network
Stephen J. O’Keefe is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Stephen J. O’Keefe have?
ScholarIQindexed works
Stephen J. O’Keefe has 553 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Stephen J. O’Keefe have?
ScholarIQcitation count
Stephen J. O’Keefe has 23,681 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Stephen J. O’Keefe?
ScholarIQh-index
Stephen J. O’Keefe has an h-index of 75 in OpenAlex.
What is the i10-index of Stephen J. O’Keefe?
ScholarIQi10-index
Stephen J. O’Keefe has an i10-index of 246 in OpenAlex.
What is the ORCID of Stephen J. O’Keefe?
ScholarIQorcid
The ORCID for Stephen J. O’Keefe is on the source record.
What is the OpenAlex record for Stephen J. O’Keefe?
ScholarIQopenalex
The OpenAlex for Stephen J. O’Keefe is on the source record.
What are the most-cited papers on Stephen J. O’Keefe?
ScholarIQmost cited works
Pembrolizumab for Persistent, Recurrent, or Metastatic Cervical Cancer
Nicoletta Colombo, Coraline Dubot, Domenica Lorusso, M. Valeria Cáceres, Kosei Hasegawa, Ronnie Shapira‐Frommer, Krishnansu S. Tewari, Pamela Salman, Edwin Hoyos Usta, Eduardo Yañez, Mahmut Gümüş, Mivael Olivera Hurtado de Mendoza, Vanessa Samouëlian, Vincent Castonguay, Arkhipov Alexander, Sarper Toker, Kan Li, Stephen J. O’Keefe, Bradley J. Monk
Short Bowel Syndrome and Intestinal Failure: Consensus Definitions and Overview
Stephen J. O’Keefe, Alan L. Buchman, Thomas Fishbein, Khursheed N. Jeejeebhoy, Palle Bekker Jeppesen, Jonathan Shaffer
Teduglutide Reduces Need for Parenteral Support Among Patients With Short Bowel Syndrome With Intestinal Failure
Palle Bekker Jeppesen, M. Pertkiewicz, Bernard Messing, Kishore Iyer, Douglas L. Seidner, Stephen J. O’Keefe, Alastair Forbes, Hartmut Heinze, B. Joelsson
Randomised placebo-controlled trial of teduglutide in reducing parenteral nutrition and/or intravenous fluid requirements in patients with short bowel syndrome
Palle Bekker Jeppesen, Richard Gilroy, M. Pertkiewicz, Johane P. Allard, Bernard Messing, Stephen J. O’Keefe
Pembrolizumab or placebo with chemoradiotherapy followed by pembrolizumab or placebo for newly diagnosed, high-risk, locally advanced cervical cancer (ENGOT-cx11/GOG-3047/KEYNOTE-A18): a randomised, double-blind, phase 3 clinical trial
Domenica Lorusso, Yang Xiang, Kosei Hasegawa, Giovanni Scambia, Manuel Leiva, Pier Ramos-Elías, Alejandro Acevedo, Vladyslav Sukhin, Noelle Cloven, Andrea Juliana Gomes, Fernando Contreras Mejía, Ari Reiss, Ali̇ Ayhan, Jung‐Yun Lee, Valeriya Saevets, Flora Zagouri, Lucy Gilbert, Jalid Sehouli, Ekkasit Tharavichitkul, Kristina Lindemann, Roberta Lazzari, Chih‐Long Chang, Rudolf Lampé, Hong Zhu, Ana Oaknin, Melissa Christiaens, Stephan Polterauer, Tomoka Usami, Kan Li, Karin Yamada, Sarper Toker, Stephen J. O’Keefe, Sandro Pignata, Linda Duska